Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Experimental studies indicate a bidirectional, functional relationship between glucocorticoids and the endocannabinoid system; however, the effects of repeated glucocorticoid treatment on the endocannabinoid system have not been examined. In this study, we treated male rats with either a single dose or a 21‐day course of treatment with corticosterone (20 mg/kg) and measured hippocampal cannabinoid CB 1 receptor expression and endocannabinoid content. The 21‐day, but not the single, administration of corticosterone significantly reduced both the binding site density and amount of protein of the hippocampal cannabinoid CB 1 receptor without affecting affinity for the CB 1 receptor agonist, [3 H]CP55940. With regard to hippocampal endocannabinoid content, acute corticosterone treatment resulted in a significant reduction in anandamide but did not affect 2‐arachidonylglycerol, while repeated corticosterone treatment did not alter content of either anandamide or 2‐arachidonylglycerol. These data support the hypothesis that the cannabinoid CB 1 receptor is under negative regulation by glucocorticoids in the hippocampus, and suggest that hippocampal cannabinoid CB 1 receptor signaling could be reduced under conditions associated with hypersecretion of glucocorticoids, such as chronic stress. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614 · cited 2×
“The hippocampus is exquisitely sensitive to glucocorticoids and exhibits an abundance of both type I and type II corticosteroid receptors (De Kloet et al., 1998).”
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
Glucocorticoids, depression, and mood disorders: Structural remodeling in the brain
McEwen, B. S. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.008 · Cited by 687
Jiang, W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25509 · Cited by 527 · cited 2×
“, 2002; Chevaleyre and Castillo, 2004) and regulates progenitor cell proliferation and neurogenesis in the hippocampus (Jin et al., 2004; Aguado et al., 2005; Jiang et al., 2005; Hill et al., 2006).”
Patel, S., Roelke, C. T., Rademacher, D. J., Cullinan, W. E., & Hillard, C. J. (2004) · Endocrinology · doi:10.1210/en.2004-0638 · Cited by 475 · cited 3×
“Support for this hypothesis comes from studies in the hypothalamus, where repeated stress exposure increases 2-AG content (Patel et al., 2004).”
Self-citationHill, M. N., Patel, S., Carrier, E. J., Rademacher, D. J., Ormerod, B. K., Hillard, C. J., & Gorzalka, B. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300601 · Cited by 363 · cited 12×
“The ability of corticosteroid treatment to robustly reduce CB1 receptor density in the hippocampus parallels our recent findings that 21 days of chronic, unpredictable stress also reduces hippocampal CB1 receptor density in rats (Hill et al., 2005b).”
InfluentialSelf-citationCota, D., Steiner, M.-A., Marsicano, G., Cervino, C., Herman, J. P., Grübler, Y., Stalla, J., Pasquali, R., Lutz, B., Stalla, G. K., et al. (2007) · Endocrinology · doi:10.1210/en.2005-1649 · Cited by 205 · cited 4×
“A recent study by Cota et al. demonstrates that endocannabinoid/CB1 receptor signaling could regulate the expression of glucocorticoid receptors in the hippocampus (Cota et al., 2007).”
InfluentialHill, M. N., Ho, W.-S. V., Meier, S. E., Gorzalka, B. B., & Hillard, C. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.058 · Cited by 40 · cited 9×
“The ability of corticosteroid treatment to robustly reduce CB1 receptor density in the hippocampus parallels our recent findings that 21 days of chronic, unpredictable stress also reduces hippocampal CB1 receptor density in rats (Hill et al., 2005b).”
InfluentialSelf-citationPryce, G., Giovannoni, G., & Baker, D. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00159-9 · Cited by 22 · cited 2×
“…of adrenal steroid actions through adrenalectomy or pharmacological blockade of the glucocorticoid receptor potentiates the physiological, endocrine, and behavioral effects of administration of cannabinoid CB1 receptor agonists (Gordon et al., 1978; Jackson and Murphy, 1997; Pryce et al., 2003).”
Cited by
Neurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 660
Self-citationCirculating Endocannabinoids: From Whence Do They Come and Where are They Going?
Hillard, C. J. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.130 · Cited by 445
Self-citationCampolongo, P., Roozendaal, B., Trezza, V., Hauer, D., Schelling, G., McGaugh, J. L., & Cuomo, V. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900835106 · Cited by 294
The endocannabinoid system in obesity and type 2 diabetes
Di Marzo, V. (2008) · Diabetologia · doi:10.1007/s00125-008-1048-2 · Cited by 281
Karatsoreos, I. N., Bhagat, S. M., Bowles, N. P., Weil, Z. M., Pfaff, D. W., & McEwen, B. S. (2010) · Endocrinology · doi:10.1210/en.2009-1436 · Cited by 260
Metadata
- Authors
- Hill, M. N., Carrier, E. J., Ho, W. ‐. V., Shi, L., Patel, S., Gorzalka, B. B., & Hillard, C. J.
- Venue
- Hippocampus
- Publisher
- Wiley
- Published
- 2007-12-03
- Volume
- 18
- Issue
- 2
- Pages
- 221-226
- ISSN
- 1050-9631 (ISSN-L)
- 1098-1063
- OpenAlex
- W2000809493
- Cited by
- 96
- References
- 9
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.